Currency fluctuations are a major concern for Global Fund stakeholders, particularly recipient countries whose domestic currency can experience significant shifts over relatively short periods of time. The strength of both the US dollar and the Euro in recent years has further exacerbated this issue for many countries.
The Government of Azerbaijan has stepped up its funding for HIV, TB and malaria as a result of the departure or anticipated departure of several donors. The government has started funding opiate substitution therapy (OST) and has begun procuring antiretroviral drugs (ARVs), sufficient to meet 20% of the national need.
The Global Fund Board has approved three of the seven Round 7 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are a malaria proposal from Azerbaijan that will cost $2.5 million over the first two years, a TB proposal from Cambodia that will cost $8.7 million, and a TB proposal from Zambia that will cost $4.1 million.